Csenge Advisory Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-387	Closed	-$276K	–	733
2024 Q4	$276K	Sell	387 -76	-16%	-$63.8K	0.02%	568
2024 Q3	$470K	Buy	463 +41	+10%	+$45.6K	0.02%	435
2024 Q2	$444K	Sell	422 -27	-6%	-$26.2K	0.03%	432
2024 Q1	$432K	Buy	449 +49	+12%	+$46.6K	0.02%	467
2023 Q4	$351K	Buy	400 +107	+37%	+$88.1K	0.02%	488
2023 Q3	$241K	Buy	+293	New	+$230K	0.02%	540
2023 Q2	–	Sell	-264	Closed	-$217K	–	691
2023 Q1	$217K	Sell	264 -14	-5%	-$10.6K	0.02%	539
2022 Q4	$201K	Buy	+278	New	+$205K	0.02%	561
2022 Q2	–	Sell	-302	Closed	-$211K	–	654
2022 Q1	$211K	Buy	+302	New	+$191K	0.02%	593
2021 Q1	–	Sell	-417	Closed	-$201K	–	517
2020 Q4	$201K	Sell	417 -774	-65%	-$418K	0.02%	411
2020 Q3	$693K	Buy	1,191 +3	+0.3%	+$1.82K	0.1%	172
2020 Q2	$741K	Buy	1,188 +546	+85%	+$310K	0.11%	144
2020 Q1	$313K	Buy	+642	New	+$265K	0.08%	207
2018 Q4	–	Sell	-3	Closed	-$1K	–	1183
2018 Q3	$1K	Buy	+3	New	+$1.14K	﹤0.01%	911